CPA
CVS icon

Cardiff Park Advisors’s CVS Health CVS Stock Holding History

Cardiff Park Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,791
Closed -$224K – 344
2024
Q2 		$224K Buy
3,791
+8
+0.2% +$500 0.02% 235
2024
Q1 		$302K Buy
3,783
+8
+0.2% +$611 0.03% 204
2023
Q4 		$298K Buy
3,775
+8
+0.2% +$569 0.03% 187
2023
Q3 		$263K Buy
3,767
+611
+19% +$43.3K 0.03% 184
2023
Q2 		$218K Buy
3,156
+7
+0.2% +$498 0.03% 220
2023
Q1 		$234K Sell
3,149
-434
-12% -$36.4K 0.03% 209
2022
Q4 		$334K Sell
3,583
-40
-1% -$3.86K 0.05% 185
2022
Q3 		$346K Buy
3,623
+576
+19% +$57K 0.05% 170
2022
Q2 		$282K Buy
3,047
+99
+3% +$9.66K 0.04% 197
2022
Q1 		$298K Sell
2,948
-87
-3% -$9.14K 0.04% 190
2021
Q4 		$313K Buy
+3,035
New +$280K 0.04% 185

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cardiff Park Advisors's CVS Position: Q3 2024 in Review

Cardiff Park Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 3,791 shares — an estimated $224K sold.

Cardiff Park Advisors first reported a position in CVS in Q4 2021 and held it in 11 quarters. The position peaked at $346K in Q3 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Cardiff Park Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Cardiff Park Advisors sold 3,791 CVS Health shares in Q3 2024, an estimated $224K.
  • Cardiff Park Advisors first reported a position in CVS Health in Q4 2021 and held it in 11 quarters.
  • Cardiff Park Advisors's CVS Health position peaked at $346K in Q3 2022.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Cardiff Park Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.